NCT00432341View on ClinicalTrials.gov

Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

PHASE4TerminatedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

June 30, 2009

Conditions
Spasmodic Torticollis
Interventions
BIOLOGICAL

botulinum toxin type A

200 Units at Visit 1 (Day 1)

BIOLOGICAL

botulinum toxin type A

500 Units at Visit 1 (Day 1)

Trial Locations (3)

Unknown

Buenos Aires

Parkville

New Delhi

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY